NEW YORK (GenomeWeb) – Becton Dickinson reported today that its fiscal first quarter revenues rose 5 percent year over year, largely due to a 9 percent increase in revenues from its life sciences business.

For the three months ended Dec. 31, the company posted revenues of $3.08 billion, compared to $2.92 billion in the year-ago quarter, beating Wall Street analysts' average estimate of $3.05 billion. On a currency-neutral basis, revenues grew 4 percent, the firm said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.